JULIE LAM: Open Payments
NPI 1346639671 · LOS GATOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,982 in 126 payments from 20 companies in 2025. Trend: 2023 $1,517 · 2024 $14,790 · 2025 $10,982
Speaker / faculty: $6,798Food & beverage: $3,761Travel & lodging: $212Education: $210
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 21 | $7,500 |
| GENZYME CORPORATION | 14 | $643 |
| Janssen Biotech, Inc. | 14 | $459 |
| ABBVIE INC. | 18 | $407 |
| Galderma Laboratories, L.P. | 6 | $333 |
| Arcutis Biotherapeutics, Inc. | 3 | $275 |
| PFIZER INC. | 6 | $231 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $196 |
| Incyte Corporation | 12 | $195 |
| Lilly USA, LLC | 7 | $170 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Zoryve, RINVOQ, OPZELURA, TALTZ, SKYRIZI.
Industry payments across CA — which companies pay providers there.
